surmount studies tirzepatide trials for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial SURMOUNT-1 Trial ESC 2025: post-hoc SURMOUNT-5 data

Doctors recommend patients carefully stand from a sitting or laying posture to reduce the risk of dizziness and lightheadedness

Adverse events are mostly gastrointestinal

The Big Picture: Where Tirzepatide Fits Among Weight Loss Medications Today there are six FDA-approved medications most commonly prescribed for chronic weight management: Tirzepatide (brand name Zepbound) weekly injection, FDA-approved for weight management in November 20234 Semaglutide (brand names Wegovy and Ozempic) weekly injection Liraglutide (brand name Saxenda) daily injection Phentermine (often combined with topiramate as Qsymia) daily oral pill Naltrexone-bupropion (brand name Contrave) daily oral pill Orlistat (brand names Xenical and Alli) oral capsule with meals In large clinical trials, the average percent body weight lost over 1218 months looks roughly like this:[1][1] Tirzepatide: about 20% Semaglutide: about 14% Phentermine/topiramate: about 9% Liraglutide: about 5% Naltrexone-bupropion: about 5% Orlistat: about 3% Tirzepatide is, on paper, the most effective

Some clinical studies have documented reductions in high-sensitivity C-reactive protein (hsCRP) among patients treated with tirzepatide for type 2 diabetes or obesity

Skin Brightening and Whitening: It naturally lightens dark spots, hyperpigmentation, and uneven skin tone by preventing the development of melanin, which gives you a glowing appearance

I think youre seeing a range of different approaches